Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Mitchell

Showing results (921-930 of 1,024) with videos related to

Pageof 103
Sort By:
Plos Genetics|May 21, 2010
Common genetic variants near the Brittle Cornea Syndrome locus ZNF469 influence the blinding disease risk factor central corneal thicknessYi Lu, David P Dimasi, Pirro G Hysi, et al.
Journal of Medicinal Chemistry|September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonistsDahui Zhou, Gary P Stack, Jennifer Lo, et al.
Plos One|May 13, 2009
Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degenerationJohn Paul SanGiovanni, Dan E Arking, Sudha K Iyengar, et al.
Ophthalmology. Retina|April 18, 2021
Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2Kelvin Yi Chong Teo, Srinivas R Sadda, Chui Ming Gemmy Cheung, et al.
American Journal of Ophthalmology|June 1, 2014
Lipids, lipid genes, and incident age-related macular degeneration: the three continent age-related macular degeneration consortiumRonald Klein, Chelsea E Myers, Gabriëlle H S Buitendijk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancerAndrew M Scott, Greg Wiseman, Sydney Welt, et al.
Investigative Ophthalmology & Visual Science|July 9, 2013
Mutational analysis of MIR184 in sporadic keratoconus and myopiaJudith Lechner, Ha Ae Bae, Jasenka Guduric-Fuchs, et al.
The British Journal of Ophthalmology|January 22, 2017
Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium reportNichole Joachim, Johanna Maria Colijn, Annette Kifley, et al.
Ophthalmology Science|April 3, 2023
No Strong Association between the Apolipoprotein E E4 Allele and Glaucoma: A Multicohort StudySean Mullany, Santiago Diaz-Torres, Joshua M Schmidt, et al.
Ophthalmology and Therapy|December 13, 2024
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular DegenerationAnat Loewenstein, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Pageof 103

Showing results (921-930 of 1,024) with videos related to

Sort By:
Pageof 103
Plos Genetics|May 21, 2010
Common genetic variants near the Brittle Cornea Syndrome locus ZNF469 influence the blinding disease risk factor central corneal thicknessYi Lu, David P Dimasi, Pirro G Hysi, et al.
Journal of Medicinal Chemistry|September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonistsDahui Zhou, Gary P Stack, Jennifer Lo, et al.
Plos One|May 13, 2009
Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degenerationJohn Paul SanGiovanni, Dan E Arking, Sudha K Iyengar, et al.
Ophthalmology. Retina|April 18, 2021
Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2Kelvin Yi Chong Teo, Srinivas R Sadda, Chui Ming Gemmy Cheung, et al.
American Journal of Ophthalmology|June 1, 2014
Lipids, lipid genes, and incident age-related macular degeneration: the three continent age-related macular degeneration consortiumRonald Klein, Chelsea E Myers, Gabriëlle H S Buitendijk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancerAndrew M Scott, Greg Wiseman, Sydney Welt, et al.
Investigative Ophthalmology & Visual Science|July 9, 2013
Mutational analysis of MIR184 in sporadic keratoconus and myopiaJudith Lechner, Ha Ae Bae, Jasenka Guduric-Fuchs, et al.
The British Journal of Ophthalmology|January 22, 2017
Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium reportNichole Joachim, Johanna Maria Colijn, Annette Kifley, et al.
Ophthalmology Science|April 3, 2023
No Strong Association between the Apolipoprotein E E4 Allele and Glaucoma: A Multicohort StudySean Mullany, Santiago Diaz-Torres, Joshua M Schmidt, et al.
Ophthalmology and Therapy|December 13, 2024
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular DegenerationAnat Loewenstein, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Pageof 103